Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for Predicting Parathyroidectomy Outcome in Primary Hyperparathyroidism
NCT02227264Completed
- Sponsor
- Karolinska University Hospital
- Start
- Jun 2014
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cinacalcet in primary hyperparathyroidism (PHPT), sponsored by Karolinska University Hospital. Primary endpoint: Quality of Life Questionnaire-Core 30 (QLQ-C30). Started Jun 2014; status: completed.
02
Drugs
cinacalcet
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NCT02227264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02227264.